Quantitative analysis of energy metabolic pathways in MCF-7 breast cancer cells by selected reaction monitoring assay

Molecular and Cellular Proteomics

Volumn 11, Issue 8, 2012, Pages 422-434

  Drabovich, Andrei P ^a   Pavlou, Maria P ^b   Dimitromanolakis, Apostolos ^c   Diamandis, Eleftherios P ^a,b,c  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; GLUCOSE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; ISOCITRATE DEHYDROGENASE 2; PENTOSE PHOSPHATE;

ACCURACY; ARTICLE; BREAST CANCER; BREAST CELL; CANCER CELL; CELL ASSAY; CELL ENERGY; CELL GROWTH; CELL HYPOXIA; CELL METABOLISM; CELL STIMULATION; CITRIC ACID CYCLE; CONTROLLED STUDY; ENERGY METABOLISM; GLUCONEOGENESIS; GLYCOLYSIS; HUMAN; HUMAN CELL; MASS SPECTROMETER; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ANALYSIS;

ALGORITHMS; AMINO ACID SEQUENCE; BREAST NEOPLASMS; CELL HYPOXIA; CELL LINE; CELL PROLIFERATION; CHROMATOGRAPHY, LIQUID; CITRIC ACID CYCLE; ENERGY METABOLISM; ESTRADIOL; GALACTOSE; GLUCOSE; GLUTAMINE; GLYCOLYSIS; HUMANS; LINEAR MODELS; MASS SPECTROMETRY; MCF-7 CELLS; METABOLIC NETWORKS AND PATHWAYS; MOLECULAR SEQUENCE DATA; PENTOSE PHOSPHATE PATHWAY; PEPTIDES; PROTEOME; PROTEOMICS;

MAMMALIA;

EID: 84863628292     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M111.015214     Document Type: Article

References (56)

1. Gatenby, R. A., and Gillies, R. J. (2004) Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer 4, 891-899
2. DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., and Thompson, C. B. (2008) The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 7, 11-20
3. Warburg, O. (1956) On respiratory impairment in cancer cells. Science 124, 269-270
4. Hanahan, D., and Weinberg, R. A. (2011) Hallmarks of cancer: the next generation. Cell 144, 646-674
5. Giovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., and Yee, D. (2010) Diabetes and cancer: a consensus report. CA Cancer J. Clin. 60, 207-221
6. Gasparre, G., Porcelli, A. M., Bonora, E., Pennisi, L. F., Toller, M., Iommarini, L., Ghelli, A., Moretti, M., Betts, C. M., Martinelli, G. N., Ceroni, A. R., Curcio, F., Carelli, V., Rugolo, M., Tallini, G., and Romeo, G. (2007) Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors. Proc. Natl. Acad. Sci. U.S.A. 104, 9001-9006
7. Duarte, N. C., Becker, S. A., Jamshidi, N., Thiele, I., Mo, M. L., Vo, T. D., Srivas, R., and Palsson, B. Ø. (2007) Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc. Natl. Acad. Sci. U.S.A. 104, 1777-1782
8. Ramanathan, A., Wang, C., and Schreiber, S. L. (2005) Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements. Proc. Natl. Acad. Sci. U.S.A. 102, 5992-5997
9. Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., Friedman, H., Friedman, A., Reardon, D., Herndon, J., Kinzler, K. W., Velculescu, V. E., Vogelstein, B., and Bigner, D. D. (2009) IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360, 765-773
10. Mardis, E. R., Ding, L., Dooling, D. J., Larson, D. E., McLellan, M. D., Chen, K., Koboldt, D. C., Fulton, R. S., Delehaunty, K. D., McGrath, S. D., Fulton, L. A., Locke, D. P., Magrini, V. J., Abbott, R. M., Vickery, T. L., Reed, J. S., Robinson, J. S., Wylie, T., Smith, S. M., Carmichael, L., Eldred, J. M., Harris, C. C., Walker, J., Peck, J. B., Du, F., Dukes, A. F., Sanderson, G. E., Brummett, A. M., Clark, E., McMichael, J. F., Meyer, R. J., Schindler, J. K., Pohl, C. S., Wallis, J. W., Shi, X., Lin, L., Schmidt, H., Tang, Y., Haipek, C., Wiechert, M. E., Ivy, J. V., Kalicki, J., Elliott, G., Ries, R. E., Payton, J. E., Westervelt, P., Tomasson, M. H., Watson, M. A., Baty, J., Heath, S., Shannon, W. D., Nagarajan, R., Link, D. C., Walter, M. J., Graubert, T. A., DiPersio, J. F., Wilson, R. K., and Ley, T. J. (2009) Recurring mutations found by sequencing an acute myeloid leukemia genome. N. Engl. J. Med. 361, 1058-1066
11. Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., and Cantley, L. C. (2008) The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452, 230-233
12. Gambhir, S. S. (2002) Molecular imaging of cancer with positron emission tomography. Nat. Rev. Cancer 2, 683-693
13. van den Bent, M. J., Dubbink, H. J., Marie, Y., Brandes, A. A., Taphoorn, M. J., Wesseling, P., Frenay, M., Tijssen, C. C., Lacombe, D., Idbaih, A., van Marion, R., Kros, J. M., Dinjens, W. N., Gorlia, T., and Sanson, M. (2010) IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group. Clin. Cancer Res. 16, 1597-1604
14. Tennant, D. A., Durán, R. V., and Gottlieb, E. (2010) Targeting metabolic transformation for cancer therapy. Nat. Rev. Cancer 10, 267-277
15. Picotti, P., Bodenmiller, B., Mueller, L. N., Domon, B., and Aebersold, R. (2009) Full dynamic range proteome analysis of S. cerevisiae by targeted proteomics. Cell 138, 795-806
16. Costenoble, R., Picotti, P., Reiter, L., Stallmach, R., Heinemann, M., Sauer, U., and Aebersold, R. (2011) Comprehensive quantitative analysis of central carbon and amino-acid metabolism in Saccharomyces cerevisiae under multiple conditions by targeted proteomics. Mol. Syst. Biol. 7, 464
17. Schmidt, A., Beck, M., Malmström, J., Lam, H., Claassen, M., Campbell, D., and Aebersold, R. (2011) Absolute quantification of microbial proteomes at different states by directed mass spectrometry. Mol. Syst. Biol. 7, 510
18. Drabovich, A. P., and Diamandis, E. P. (2010) Combinatorial peptide libraries facilitate development of multiple reaction monitoring assays for low-abundance proteins. J. Proteome Res. 9, 1236-1245
19. Makawita, S., Smith, C., Batruch, I., Zheng, Y., Ruckert, F., Grutzmann, R., Pilarsky, C., Gallinger, S., and Diamandis, E. P. (2011) Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers. Mol. Cell. Proteomics 10, 10.1074/mcp.M111.008599
20. Drabovich, A. P., Jarvi, K., and Diamandis, E. P. (2011) Verification of male infertility biomarkers in seminal plasma by multiplex selected reaction monitoring assay. Mol. Cell. Proteomics 10, 10.1074/mcp.M110.004127
21. Benjamini, Y., and Hochberg, Y. (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. Roy. Statist. Soc. 57, 289-300
22. Yu, Y. Q., Gilar, M., Lee, P. J., Bouvier, E. S., and Gebler, J. C. (2003) Enzyme-friendly, mass spectrometry-compatible surfactant for in-solution enzymatic digestion of proteins. Anal. Chem. 75, 6023-6028
23. Beck, M., Schmidt, A., Malmstroem, J., Claassen, M., Ori, A., Szymborska, A., Herzog, F., Rinner, O., Ellenberg, J., and Aebersold, R. (2011) The quantitative proteome of a human cell line. Mol. Syst. Biol. 7, 549
24. Prakash, A., Tomazela, D. M., Frewen, B., Maclean, B., Merrihew, G., Peterman, S., and Maccoss, M. J. (2009) Expediting the development of targeted SRM assays: using data from shotgun proteomics to automate method development. J. Proteome Res. 8, 2733-2739
25. Beynon, R. J., Doherty, M. K., Pratt, J. M., and Gaskell, S. J. (2005) Multiplexed absolute quantification in proteomics using artificial QCAT proteins of concatenated signature peptides. Nat. Methods 2, 587-589
26. Yu, K. H., Barry, C. G., Austin, D., Busch, C. M., Sangar, V., Rustgi, A. K., and Blair, I. A. (2009) Stable isotope dilution multidimensional liquid chromatography-tandem mass spectrometry for pancreatic cancer serum biomarker discovery. J. Proteome Res. 8, 1565-1576
27. Geiger, T., Cox, J., Ostasiewicz, P., Wisniewski, J. R., and Mann, M. (2010) Super-SILAC mix for quantitative proteomics of human tumor tissue. Nat. Methods 7, 383-385
28. Stergachis, A. B., MacLean, B., Lee, K., Stamatoyannopoulos, J. A., and MacCoss, M. J. (2011) Rapid empirical discovery of optimal peptides for targeted proteomics. Nat. Methods 8, 1041-1043
29. Nogueira, C. R., and Brentani, M. M. (1996) Triiodothyronine mimics the effects of estrogen in breast cancer cell lines. J. Steroid Biochem. Mol. Biol. 59, 271-279
30. Zuo, X., Lee, K., and Speicher, DW (2004) Electrophoretic prefractionation for comprehensive analysis of proteomes. In: Speicher, D. W., ed. Proteome Analysis: Interpreting the Genome, pp. 93-115, Elsevier Science, New York.
31. Carrillo, B., Yanofsky, C., Laboissiere, S., Nadon, R., and Kearney, R. E. (2010) Methods for combining peptide intensities to estimate relative protein abundance. Bioinformatics 26, 98-103
32. Zaret, K. S., and Stevens, K. A. (1990) Selection and analysis of galactose metabolic pathway variants of a mouse liver cell line. Mol. Cell. Biol. 10, 4582-4589
33. Jean, J. C., Rich, C. B., and Joyce-Brady, M. (2006) Hypoxia results in an HIF-1-dependent induction of brain-specific aldolase C in lung epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 291, L950-956
34. Semenza, G. L. (2009) Regulation of cancer cell metabolism by hypoxiainducible factor 1. Semin. Cancer Biol. 19, 12-16
35. Mense, S. M., Sengupta, A., Zhou, M., Lan, C., Bentsman, G., Volsky, D. J., and Zhang, L. (2006) Gene expression profiling reveals the profound upregulation of hypoxia-responsive genes in primary human astrocytes. Physiol. Genomics 25, 435-449
36. Lu, S., Gu, X., Hoestje, S., and Epner, D. E. (2002) Identification of an additional hypoxia responsive element in the glyceraldehyde-3-phosphate dehydrogenase gene promoter. Biochim. Biophys. Acta 1574, 152-156
37. Ortiz-Barahona, A., Villar, D., Pescador, N., Amigo, J., and del Peso, L. (2010) Genome-wide identification of hypoxia-inducible factor binding sites and target genes by a probabilistic model integrating transcription-profiling data and in silico binding site prediction. Nucleic Acids Res. 38, 2332-2345
38. Benita, Y., Kikuchi, H., Smith, A. D., Zhang, M. Q., Chung, D. C., and Xavier, R. J. (2009) An integrative genomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core response to hypoxia. Nucleic Acids Res. 37, 4587-4602
39. Ryu, K., Park, C., and Lee, Y. (2011) Hypoxia-inducible factor 1 alpha represses the transcription of the estrogen receptor alpha gene in human breast cancer cells. Biochem. Biophys. Res. Commun. 407, 831-836
40. Bourdeau, V., Deschênes, J., Métivier, R., Nagai, Y., Nguyen, D., Bretschneider, N., Gannon, F., White, J. H., and Mader, S. (2004) Genome-wide identification of high-affinity estrogen response elements in human and mouse. Mol. Endocrinol. 18, 1411-1427
41. Kocanova, S., Kerr, E. A., Rafique, S., Boyle, S., Katz, E., Caze-Subra, S., Bickmore, W. A., and Bystricky, K. (2010) Activation of estrogen-responsive genes does not require their nuclear co-localization. PLoS Genet. 6, e1000922
42. Hnatyszyn, H. J., Liu, M., Hilger, A., Herbert, L., Gomez-Fernandez, C. R., Jorda, M., Thomas, D., Rae, J. M., El-Ashry, D., and Lippman, M. E. (2010) Correlation of GREB1 mRNA with protein expression in breast cancer: validation of a novel GREB1 monoclonal antibody. Breast Cancer Res. Treat. 122, 371-380
43. Zheng, Z. Y., Bay, B. H., Aw, S. E., and Lin, V. C. (2005) A novel antiestrogenic mechanism in progesterone receptor-transfected breast cancer cells. J. Biol. Chem. 280, 17480-17487
44. Abba, M. C., Sun, H., Hawkins, K. A., Drake, J. A., Hu, Y., Nunez, M. I., Gaddis, S., Shi, T., Horvath, S., Sahin, A., and Aldaz, C. M. (2007) Breast cancer molecular signatures as determined by SAGE: correlation with lymph node status. Mol. Cancer Res. 5, 881-890
45. Taylor, K. J., Sims, A. H., Liang, L., Faratian, D., Muir, M., Walker, G., Kuske, B., Dixon, J. M., Cameron, D. A., Harrison, D. J., and Langdon, S. P. (2010) Dynamic changes in gene expression in vivo predict prognosis of tamoxifen-treated patients with breast cancer. Breast Cancer Res. 12, R39
46. Dunbier, A. K., Anderson, H., Ghazoui, Z., Folkerd, E. J., A'Hern, R., Crowder, R. J., Hoog, J., Smith, I. E., Osin, P., Nerurkar, A., Parker, J. S., Perou, C. M., Ellis, M. J., and Dowsett, M. (2010) Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor-positive breast cancer in postmenopausal women. J. Clin. Oncol. 28, 1161-1167
47. Charpentier, A. H., Bednarek, A. K., Daniel, R. L., Hawkins, K. A., Laflin, K. J., Gaddis, S., MacLeod, M. C., and Aldaz, C. M. (2000) Effects of estrogen on global gene expression: identification of novel targets of estrogen action. Cancer Res. 60, 5977-5983
48. Jiang, P., Du, W., Wang, X., Mancuso, A., Gao, X., Wu, M., and Yang, X. (2011) p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase. Nat. Cell Biol. 13, 310-316
49. Gross, S., Cairns, R. A., Minden, M. D., Driggers, E. M., Bittinger, M. A., Jang, H. G., Sasaki, M., Jin, S., Schenkein, D. P., Su, S. M., Dang, L., Fantin, V. R., and Mak, T. W. (2010) Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations. J. Exp. Med. 207, 339-344
50. Reitman, Z. J., and Yan, H. (2010) Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism. J. Natl. Cancer Inst. 102, 932-941
51. Geiger, T., Madden, S. F., Gallagher, W. M., Cox, J., and Mann, M. (2012) Proteomic portrait of human breast cancer progression identifies novel prognostic markers. Cancer Res. 72, 2428-2439
52. Soule, H. D., Maloney, T. M., Wolman, S. R., Peterson, W. D., Jr., Brenz, R., McGrath, C. M., Russo, J., Pauley, R. J., Jones, R. F., and Brooks, S. C. (1990) Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 50, 6075-6086
53. Bateman, N. W., Sun, M., Hood, B. L., Flint, M. S., and Conrads, T. P. (2010) Defining central themes in breast cancer biology by differential proteomics: conserved regulation of cell spreading and focal adhesion kinase. J. Proteome Res. 9, 5311-5324
54. Favaro, E., Lord, S., Harris, A. L., and Buffa, F. M. (2011) Gene expression and hypoxia in breast cancer. Genome Med. 3, 55
55. Nomura, D. K., Dix, M. M., and Cravatt, B. F. (2010) Activity-based protein profiling for biochemical pathway discovery in cancer. Nat. Rev. Cancer 10, 630-638
56. Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., and Selbach, M. (2011) Global quantification of mammalian gene expression control. Nature 473, 337-342